Evidence map›Paper›PMID 33235212›Full record

ArticleNature communications2020

Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages.

Michael Biggel, Basil B Xavier, James R Johnson, Karen L Nielsen, Niels Frimodt-Møller, Veerle Matheeussen, Herman Goossens, Pieter Moons, Sandra Van Puyvelde

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 82 citations in OpenAlex.

  1. UropathogenicAntibiotics (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Is Virulence GeneInfectious disease reports · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Research Progress on perinatalFrontiers in microbiology · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Comparative Analysis of ESBL Phenotypes and Antimicrobial Resistance inMicrobial drug resistance (Larchmont, N.Y.) · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 5 countries.

Michael BiggelLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. michaelbiggel@gmail.com.ORCID 0000-0002-1337-2132
Basil B XavierLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-5897-0240
James R JohnsonVeterans Affairs Medical Center and University of Minnesota, Minneapolis, MN, USA.
Karen L NielsenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-7912-1985
Niels Frimodt-MøllerDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Veerle MatheeussenLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-7217-3643
Herman GoossensLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Pieter MoonsLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Sandra Van PuyveldeLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. Sandra.VanPuyvelde@uantwerpen.be.ORCID 0000-0001-8434-5732
University of Antwerp · BERigshospitalet · DKUniversity of Cambridge · GBUniversity of Minnesota Medical Center · US

Funding

CSRD VA I01 CX000920Wellcome Trust
6 · The paper itself

Abstract

Escherichia coli is the leading cause of urinary tract infection, one of the most common bacterial infections in humans. Despite this, a genomic perspective is lacking regarding the phylogenetic distribution of isolates associated with different clinical syndromes. Here, we present a large-scale phylogenomic analysis of a spatiotemporally and clinically diverse set of 907 E. coli isolates, including 722 uropathogenic E. coli (UPEC) isolates. A genome-wide association approach identifies the (P-fimbriae-encoding) papGII locus as the key feature distinguishing invasive UPEC, defined as isolates associated with severe UTI, i.e., kidney infection (pyelonephritis) or urinary-source bacteremia, from non-invasive UPEC, defined as isolates associated with asymptomatic bacteriuria or bladder infection (cystitis). Within the E. coli population, distinct invasive UPEC lineages emerged through repeated horizontal acquisition of diverse papGII-containing pathogenicity islands. Our findings elucidate the molecular determinants of severe UTI and have implications for the early detection of this pathogen.

Indexed as

Uropathogenic Escherichia coliAdhesins, Escherichia coliDNA, BacterialEscherichia coli InfectionsFimbriae, BacterialGene Transfer, HorizontalGenome, BacterialGenome-Wide Association StudyGenomic IslandsHumansPhylogenyUrinary TractUrinary Tract InfectionsVirulence FactorsAdhesins, Escherichia coliDNA, BacterialPapGII protein, E coliVirulence Factors

Identifiers

PMID33235212
PMCPMC7686366
OpenAlexW3106832178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.